Fedenia Advisers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Fedenia Advisers's ABBV Position: Q2 2026 in Review
Fedenia Advisers opened a new position in AbbVie (ABBV) in Q2 2026: 548 shares worth $138K. The stake represents 0.03% of the portfolio and ranks #152 among its holdings. This is a return to the name: Fedenia Advisers previously reported a position in ABBV as recently as Q4 2024.
Fedenia Advisers first reported a position in ABBV in Q4 2024 and has held it in 2 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Fedenia Advisers held 548 shares of AbbVie worth $138K as of Q2 2026.
- AbbVie was a new Fedenia Advisers position in Q2 2026.
- AbbVie made up 0.03% of Fedenia Advisers's portfolio in Q2 2026, its #152 holding.
- Fedenia Advisers first reported a position in AbbVie in Q4 2024 and has held it in 2 quarters since.
- 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Fedenia Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.